New drug for leukemia improves survival rates to 90% Bashny.Net

 

Australian researchers have been testing a new cancer drug that effectively treats leukemia.

Test results on 391 the patient showed the drug Ibrutinib, struggling with slow-growing cancer of the blood (chronic lymphocytic leukemia), gives a 90 percent chance of survival, eight higher than in those receiving chemotherapy.





Moreover, the drug is less invasive than traditional forms of radiation, and is an alternative for patients whose cancer cells created a resistance to chemotherapy. The test results also showed that four out of every 10 patients entered remission within a year, compared to four out of 100 in the traditional process of irradiation.

Dr. Kom Tam confident that Ibrutinib will eventually replace chemotherapy as the main treatment for leukemia patients. According to the Tam, international testing has shown the rapid action of the drug and fewer side effects. The author added: "Patients resistant to chemotherapy have no other choice of treatment. These pills work very well when chemotherapy stops working."

 

Source: nauka24news.ru/